Prelude Therapeutics

PRLD

NASDAQHealth Care

Income Statement

Total Revenue$0

Gross Profit$0

Operating Income$-146.71M

EBITDA$-123.81M

EBIT$-127.17M

Pre-tax Income$-97.18M

Net Income$-127.17M

Cash Equivalent$23.08M

Total Debt$18M

Book Value$170.23M

Book Value Per Share3.10

Return on Equity (ROE)-96.74%

Return on Assets (ROA)-72.46%

Return on Invested Capital (ROI)-96.59%

Net Profit Margin-1816.76%

Current Ratio5.30

Quick Ratio5.21

Long-Term Debt / Equitynull